Neuroprotection against oxidative stress by estrogens: Structure- activity relationship

Molecular Pharmacology

Volumn 51, Issue 4, 1997, Pages 535-541

  Behl, Christian ^a   Skutella, Thomas ^b   Lezoualc'h, Frank ^a   Post, Anke ^a   Widmann, Martina ^a   Newton, Christopher J ^a   Holsboer, Florian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ESTRADIOL; AMYLOID BETA PROTEIN; ANTIOXIDANT; ESTRADIOL; ESTRADIOL DERIVATIVE; ESTRIOL; ESTROGEN; ESTROGEN DERIVATIVE; ESTRONE; ETHINYLESTRADIOL; GLUTAMIC ACID; HYDROGEN PEROXIDE; MESTRANOL; QUINESTROL; TESTOSTERONE;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG STRUCTURE; HIPPOCAMPUS; MOUSE; NERVE CELL CULTURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030903206     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.4.535     Document Type: Article

References (31)

1. Simpkins, J. W., M. Singh, and J. Bishop. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol. Aging Suppl. 15:195-197 (1994).
2. Paganini-Hill, A., and V. W. Henderson. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140:256-261 (1994).
3. McEwen, B. S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12:141-147 (1991).
4. Clark, J. H., and E. J. Peck. Female sex steroids, receptors and function. Monogr. Endocrinol. 14:4-36 (1979).
5. Paul, S. M., and R. H. Purdy. Neuroactive steroids. FASEB J. 6:2311-2322 (1992).
6. Ravi Subbiah, M. T., B. Kessel, M. Agrawal, R. Rajan, W. Abplanalp, and Z. Rymaszewski. J. Clin. Endocrinol. Metab. 77:1095-1097 (1993).
7. Parthasarathy, S., D. Steinberg, and J. L. Witztum. The role of oxidated low-density lipoproteins in the pathogenesis of atherosclerosis. Annu. Rev. Med. 43:219-225 (1992).
8. Coyle, J. T., and P. Puttfarcken. Oxidative stress, glutamate, and neurodegenerative disorders. Science (Washington D. C.) 262:689-695 (1993).
9. Yan, S. D., X. Cheng, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, and A. M. Schmidt. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature (Lond.) 382:685-691 (1996).
10. Miyata, M., and J. D. Smith. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat. Gen. 14:55-61 (1996).
11. Behl, C., J. B. Davis, R. Lesley, and D. Schubert. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77:817-827 (1994).
12. Behl, C., M. Widmann, T. Trapp, and F. Holsboer. 17-Beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216:473-482 (1995).
13. Goodman, Y., A. J. Bruce, B. Cheng, and M. Mattson. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1836-1844 (1996).
14. Glenner, G. G. Alzheimer's disease: its proteins and genes. Cell 52:307-308 (1988).
15. Choi, D. W. Excitotoxic cell death. J. Neurobiol. 23:1261-1276 (1992).
16. Lafon-Cazal, M., S. Pietri, M. Culcasi, and J. Bockaert. NMDA-dependent superoxide production and neurotoxicity. Nature (Lond.) 364:535-537 (1993).
17. Murphy, T. H., M. Miyamoto, A. Sastre, R. L. Schnaar, and J. T. Coyle. Glutamate toxicity in a neural cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547-1558 (1989).
18. Davis, J. B., and P. Maher. Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 652:169-173 (1994).
19. Halliwell, B. Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radical Biol. Med. 7:645-651 (1989).
20. Gorski, J. A hindsight view of early studies on the estrogen receptor: a personal history. Steroids 59:240-243 (1994).
21. Yankner, B. A., L. K. Duff, and D. A. Kirschner. Neurotrophic and neurotoxic effects of myeloid beta protein: reversal by tachykinin neuropeptides. Science (Washington D. C.) 250:279-282 (1990).
22. Jellinck, P. H., J. J. Michnovicz, and H. L. Bradlow. Influence of indole-3-carbinol on the hepatic microsomal formation of catechol estrogens. Steroids 56:446-450 (1991).
23. Braak, H., and E. Braak. Neuropathological staging of Alzheimer-related changes. Acta. Neuropathol. 82:239-259 (1991).
24. Diekmann S., R. Nitsch, and T. G. Ohm. The organotypic entorhinalhippocampal complex slice culture of adolescent rats. A model to study transcellular changes in a circuit particularly vulnerable in neurodegenerative disorders. J. Neural Transm. Suppl. 44:61-71 (1994).
25. Ferreira, A., and A. Caceres. Estrogen-enhanced neurite growth: evidence for a selective induction of tau and stable microtubules. J. Neurosci. 11:392-402 (1991).
26. Jaffe, A. B., C. D. Toran-Allerand, P. Greengard, and S. E. Gandy. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J. Biol. Chem. 269:13065-13068 (1994).
27. Honjo, H., K. Tanaka, T. Kashiwagi, M. Urabe, H. Okada, M. Hayashi, and K. Hayashi. Senile dementia - Alzheimer's type and estrogen. Hormone Metab. Res. 27:204-207 (1995).
28. Milgrom, E. Steroid hormones, in Hormones - From Molecules to Disease (E.-E. Baulieu and P. A. Kelly, eds.). Chapman and Hall, New York, 387-437 (1990).
29. Hall, E. D., K. E. Pazara, and K. L. Linseman. Sex differences in postischemic neuronal necrosis in gerbils. J. Cereb. Blood Flow Metab. 11:292-298 (1991).
30. Heikinheimo, O., and R. Kekkonen. Dose-response relationships of RU-486. Ann. Med. 25:71-76 (1993).
31. Miller, C. P., I. Jirkovsky, D. A. Hayhurst, and S. J. Adelman. In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids 61:305-308 (1996).